DEXCOM INC Insider Trading for February 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in DEXCOM INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in DEXCOM INC for February 2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 24 2017 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | EVP, Chief Commerci ... | Sell | S | 78.42 | 3,182 | 249,530 | 12,733 | 15.9 K to 12.7 K (-19.99 %) |
Feb 24 2017 | DXCM | DEXCOM INC | ROPER JESS | SVP, CFO | Sell | S | 78.76 | 2,333 | 183,759 | 10,452 | 12.8 K to 10.5 K (-18.25 %) |
Feb 22 2017 | DXCM | DEXCOM INC | SAYER KEVIN R | President & CEO | Option Exercise | M | 8.79 | 10,000 | 87,900 | 23,649 | |
Feb 22 2017 | DXCM | DEXCOM INC | SAYER KEVIN R | President & CEO | Sell | S | 81.62 | 10,000 | 816,177 | 299,391 | 309.4 K to 299.4 K (-3.23 %) |
Feb 22 2017 | DXCM | DEXCOM INC | SAYER KEVIN R | President & CEO | Buy | M | 8.79 | 10,000 | 87,900 | 309,391 | 299.4 K to 309.4 K (+3.34 %) |
Feb 14 2017 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Option Exercise | M | 9.80 | 727 | 7,125 | 0 | |
Feb 14 2017 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | S | 79.30 | 2,473 | 196,109 | 103,872 | 106.3 K to 103.9 K (-2.33 %) |
Feb 14 2017 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Sell | S | 79.30 | 727 | 57,651 | 106,345 | 107.1 K to 106.3 K (-0.68 %) |
Feb 14 2017 | DXCM | DEXCOM INC | Balo Andrew K | EVP, Clinical and R ... | Buy | M | 9.80 | 727 | 7,125 | 107,072 | 106.3 K to 107.1 K (+0.68 %) |
Feb 13 2017 | DXCM | DEXCOM INC | LISTER JOHN | General Manager, EM ... | Option Exercise | M | 8.85 | 3,000 | 26,550 | 13,939 | |
Feb 13 2017 | DXCM | DEXCOM INC | LISTER JOHN | General Manager, EM ... | Sell | S | 79.73 | 3,000 | 239,204 | 70,598 | 73.6 K to 70.6 K (-4.08 %) |
Feb 13 2017 | DXCM | DEXCOM INC | LISTER JOHN | General Manager, EM ... | Buy | M | 8.85 | 3,000 | 26,550 | 73,598 | 70.6 K to 73.6 K (+4.25 %) |
Feb 13 2017 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Option Exercise | M | 9.80 | 7,000 | 68,600 | 0 | |
Feb 13 2017 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | S | 79.76 | 7,000 | 558,316 | 72,334 | 79.3 K to 72.3 K (-8.82 %) |
Feb 13 2017 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Buy | M | 9.80 | 7,000 | 68,600 | 79,334 | 72.3 K to 79.3 K (+9.68 %) |
Feb 13 2017 | DXCM | DEXCOM INC | GREGG TERRANCE H | Executive Chairman | Sell | D | 79.35 | 1,421 | 112,756 | 439,845 | 441.3 K to 439.8 K (-0.32 %) |
Feb 03 2017 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Option Exercise | M | 9.80 | 13,900 | 136,220 | 7,000 | |
Feb 03 2017 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | S | 80.00 | 13,900 | 1,112,000 | 72,334 | 86.2 K to 72.3 K (-16.12 %) |
Feb 03 2017 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Buy | M | 9.80 | 13,900 | 136,220 | 86,234 | 72.3 K to 86.2 K (+19.22 %) |